p38 MAP Kinase Inhibitor Ⅵ

• UNSPSC Description:

  p38 MAP Kinase Inhibitor VI (compound c32) is a p38 MAPK inhibitor with an inhibition rate of 24%[1].

• Target Antigen:

  p38 MAPK

• Type:

  Reference compound

• Related Pathways:

  MAPK/ERK Pathway

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  cancer

• Assay Protocol:

  https://www.medchemexpress.com/p38-map-kinase-inhibitor.html

• Purity:

  98.0

• Solubility:

  DMSO : 5 mg/mL (ultrasonic)

• Smiles:

  FC1=CC=C(C(CSC2=C(C(C)=C(C)S3)C3=NC=N2)=O)C=C1

• Molecular Weight:

  332.42

• References & Citations:

  [1]Cheeseright TJ, et al. Novel lead structures for p38 MAP kinase via FieldScreen virtual screening. J Med Chem. 2009 Jul 23;52(14):4200-9.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, protect from light)

• Clinical Information:

  No Development Reported

• CAS Number:

  421578-46-3